Gary W Pace
Insider
First SEC filing: Feb. 23, 2010 · Latest: Feb. 23, 2010
Insider at
Insider transactions
3 buys (P)
0 sells (S)
Net: $1,040,036
Avg return of open purchases vs now: -15.7%
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 14, 2026 | CRDF | P | 687,285 | · | · | 687,285 Direct | · | Acquired | (price as of 2026-10-02) |
| July 14, 2026 | CRDF | P | 687,285 | $1.46 | $1,003,436 | 2,043,661 Direct | +50.67% | Acquired | -23.3% (price as of 2026-10-02) |
| June 18, 2026 | CRDF | P | 30,000 | $1.22 | $36,600 | 1,356,376 Direct | +2.26% | Acquired | -8.2% (price as of 2026-10-02) |
| June 11, 2026 | CRDF | A | 40,565 | · | · | 228,104 Direct | +21.63% | Acquired | (price as of 2026-10-02) |
| July 30, 2025 | CRDF | P | 15,000 | $2.45 | $36,750 | 1,345,676 Indirect | +1.13% | Acquired | -54.3% (price as of 2026-10-02) |
| July 30, 2025 | CRDF | P | 275,000 | $2.45 | $673,750 | 1,330,676 Direct | +26.05% | Acquired | -54.3% (price as of 2026-10-02) |
| June 26, 2025 | CRDF | A | 40,565 | · | · | 187,539 Direct | +27.60% | Acquired | (price as of 2026-10-02) |
| Dec. 11, 2024 | CRDF | P | 11,500 | $2.60 | $29,900 | 1,059,376 Indirect | +1.10% | Acquired | -56.9% (price as of 2026-10-02) |
| Dec. 11, 2024 | CRDF | P | 350,115 | $2.60 | $910,299 | 1,047,876 Direct | +50.18% | Acquired | -56.9% (price as of 2026-10-02) |
| June 27, 2024 | CRDF | A | 29,700 | · | · | 146,974 Direct | +25.33% | Acquired | (price as of 2026-10-02) |
| March 8, 2024 | PCRX | S | 90,000 | $30.60 | $2,754,000 | 22,127 Direct | -80.27% | Disposed | -17.6% (price as of 2026-10-02) |
| March 7, 2024 | PCRX | S | 28,257 | $30.81 | $870,598 | 112,127 Direct | -20.13% | Disposed | -18.2% (price as of 2026-10-02) |
| March 6, 2024 | PCRX | S | 1,066 | $29.67 | $31,628 | 140,384 Direct | -0.75% | Disposed | -15.0% (price as of 2026-10-02) |
| Dec. 19, 2023 | CRDF | P | 30,000 | $1.37 | $41,100 | 697,761 Direct | +4.49% | Acquired | -18.2% (price as of 2026-10-02) |
| Nov. 10, 2023 | CRDF | P | 22,950 | $0.98 | $22,491 | 667,761 Direct | +3.56% | Acquired | 14.3% (price as of 2026-10-02) |
| June 15, 2023 | CRDF | A | 27,700 | · | · | 117,274 Direct | +30.92% | Acquired | (price as of 2026-10-02) |
| June 14, 2023 | PCRX | A | 12,925 | · | · | 12,925 Direct | · | Acquired | (price as of 2026-10-02) |
| June 14, 2023 | PCRX | A | 1,775 | · | · | 141,450 Direct | +1.27% | Acquired | (price as of 2026-10-02) |
| May 11, 2023 | PCRX | M | 7,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 11, 2023 | PCRX | S | 5,015 | $41.78 | $209,527 | 139,675 Direct | -3.47% | Disposed | -39.7% (price as of 2026-10-02) |
| May 11, 2023 | PCRX | M | 7,000 | $29.90 | $209,300 | 144,690 Direct | +5.08% | Acquired | -15.7% (price as of 2026-10-02) |
| Sept. 15, 2022 | CRDF | P | 150,000 | $1.71 | $256,500 | 644,811 Direct | +30.31% | Acquired | -34.5% (price as of 2026-10-02) |
| June 8, 2022 | PCRX | A | 8,225 | · | · | 8,225 Direct | · | Acquired | (price as of 2026-10-02) |
| June 8, 2022 | PCRX | A | 1,160 | · | · | 137,690 Direct | +0.85% | Acquired | (price as of 2026-10-02) |
| March 9, 2022 | CRDF | A | 26,800 | · | · | 89,574 Direct | +42.69% | Acquired | (price as of 2026-10-02) |
| March 3, 2022 | PCRX | M | 7,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 3, 2022 | PCRX | M | 7,000 | $10.81 | $75,670 | 136,530 Direct | +5.40% | Acquired | 133.2% (price as of 2026-10-02) |
| March 1, 2022 | PCRX | M | 1,166 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 1, 2022 | PCRX | M | 193 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 1, 2022 | PCRX | S | 1,359 | $67.75 | $92,072 | 129,530 Direct | -1.04% | Disposed | -62.8% (price as of 2026-10-02) |
| March 1, 2022 | PCRX | M | 1,166 | $11.02 | $12,849 | 130,889 Direct | +0.90% | Acquired | 128.8% (price as of 2026-10-02) |
| March 1, 2022 | PCRX | M | 193 | $11.02 | $2,127 | 129,723 Direct | +0.15% | Acquired | 128.8% (price as of 2026-10-02) |
| Feb. 28, 2022 | PCRX | M | 18,834 | · | · | 1,166 Direct | -94.17% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2022 | PCRX | M | 9,807 | · | · | 193 Direct | -98.07% | Disposed | (price as of 2026-10-02) |
| Feb. 28, 2022 | PCRX | S | 28,641 | $66.83 | $1,914,078 | 129,530 Direct | -18.11% | Disposed | -62.3% (price as of 2026-10-02) |
| Feb. 28, 2022 | PCRX | M | 18,834 | $11.02 | $207,551 | 158,171 Direct | +13.52% | Acquired | 128.8% (price as of 2026-10-02) |
| Feb. 28, 2022 | PCRX | M | 9,807 | $11.02 | $108,073 | 139,337 Direct | +7.57% | Acquired | 128.8% (price as of 2026-10-02) |
| Sept. 21, 2021 | CRDF | P | 30,000 | $6.75 | $202,500 | 494,811 Direct | +6.45% | Acquired | -83.4% (price as of 2026-10-02) |
| June 10, 2021 | CRDF | A | 22,000 | · | · | 62,774 Direct | +53.96% | Acquired | (price as of 2026-10-02) |
| June 9, 2021 | PCRX | A | 1,066 | · | · | 129,530 Direct | +0.83% | Acquired | (price as of 2026-10-02) |
| June 9, 2021 | PCRX | A | 7,626 | · | · | 7,626 Direct | · | Acquired | (price as of 2026-10-02) |
| May 13, 2021 | PCRX | G | 1,485 | · | · | 128,464 Direct | -1.14% | Disposed | (price as of 2026-10-02) |
| March 23, 2021 | CRDF | P | 5,000 | $10.20 | $51,000 | 459,811 Direct | +1.10% | Acquired | -89.0% (price as of 2026-10-02) |
| March 23, 2021 | CRDF | P | 2,500 | $10.21 | $25,525 | 462,311 Direct | +0.54% | Acquired | -89.0% (price as of 2026-10-02) |
| March 23, 2021 | CRDF | P | 2,500 | $10.31 | $25,775 | 464,811 Direct | +0.54% | Acquired | -89.1% (price as of 2026-10-02) |
| March 18, 2021 | CRDF | P | 1,000 | $10.58 | $10,580 | 452,811 Direct | +0.22% | Acquired | -89.4% (price as of 2026-10-02) |
| March 18, 2021 | CRDF | P | 2,000 | $10.54 | $21,080 | 454,811 Direct | +0.44% | Acquired | -89.4% (price as of 2026-10-02) |
| March 4, 2021 | CRDF | P | 1,500 | $9.26 | $13,890 | 451,811 Direct | +0.33% | Acquired | -87.9% (price as of 2026-10-02) |
| Sept. 25, 2020 | PCRX | M | 70,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Sept. 25, 2020 | PCRX | M | 70,000 | $16.67 | $1,166,900 | 129,949 Direct | +116.77% | Acquired | 51.2% (price as of 2026-10-02) |
| Sept. 16, 2020 | CRDF | P | 1,700 | $5.69 | $9,673 | 449,461 Direct | +0.38% | Acquired | -80.3% (price as of 2026-10-02) |
| Sept. 16, 2020 | CRDF | P | 850 | $5.71 | $4,854 | 450,311 Direct | +0.19% | Acquired | -80.4% (price as of 2026-10-02) |
| June 17, 2020 | CRDF | A | 28,858 | · | · | 40,774 Direct | +242.18% | Acquired | (price as of 2026-10-02) |
| June 9, 2020 | PCRX | A | 8,027 | · | · | 8,027 Direct | · | Acquired | (price as of 2026-10-02) |
| June 9, 2020 | PCRX | A | 1,260 | · | · | 59,949 Direct | +2.15% | Acquired | (price as of 2026-10-02) |
| May 11, 2020 | CRDF | P | 447,761 | $1.34 | $600,000 | 447,761 Indirect | · | Acquired | -16.4% (price as of 2026-10-02) |
| April 16, 2020 | CRDF | A | 11,916 | · | · | 11,916 Direct | · | Acquired | (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 7,438 | $1.61 | $11,975 | 53,689 Direct | +16.08% | Acquired | 1465.8% (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 5,000 | $13.98 | $69,900 | 58,689 Direct | +9.31% | Acquired | 80.3% (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 4,649 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 5,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 7,438 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 4,649 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 4,649 | $1.61 | $7,485 | 46,251 Direct | +11.17% | Acquired | 1465.8% (price as of 2026-10-02) |
| March 12, 2020 | PCRX | M | 4,649 | $1.61 | $7,485 | 41,602 Direct | +12.58% | Acquired | 1465.8% (price as of 2026-10-02) |
| June 5, 2019 | PCRX | A | 8,437 | · | · | 8,437 Direct | · | Acquired | (price as of 2026-10-02) |
| June 5, 2019 | PCRX | A | 4,134 | · | · | 36,953 Direct | +12.60% | Acquired | (price as of 2026-10-02) |
| Nov. 19, 2018 | PCRX | P | 4,500 | $46.18 | $207,810 | 32,819 Direct | +15.89% | Acquired | -45.4% (price as of 2026-10-02) |
| Nov. 7, 2018 | PCRX | P | 4,000 | $51.29 | $205,160 | 28,319 Direct | +16.45% | Acquired | -50.8% (price as of 2026-10-02) |
| June 13, 2018 | PCRX | A | 4,693 | · | · | 4,693 Direct | · | Acquired | (price as of 2026-10-02) |
| June 13, 2018 | PCRX | A | 782 | · | · | 24,319 Direct | +3.32% | Acquired | (price as of 2026-10-02) |
| May 8, 2018 | RMD | M | 28,403 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| May 8, 2018 | RMD | S | 28,403 | $97.37 | $2,765,600 | 100,578 Direct | -22.02% | Disposed | 124.8% (price as of 2026-10-02) |
| May 8, 2018 | RMD | M | 28,403 | $27.58 | $783,355 | 128,981 Direct | +28.24% | Acquired | 693.7% (price as of 2026-10-02) |
| Nov. 16, 2017 | RMD | A | 2,991 | · | · | 100,578 Direct | +3.06% | Acquired | (price as of 2026-10-02) |
| June 15, 2017 | RMD | M 10b5-1 | 22,660 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 15, 2017 | RMD | S 10b5-1 | 22,660 | $76.00 | $1,722,160 | 97,587 Direct | -18.84% | Disposed | 188.0% (price as of 2026-10-02) |
| June 15, 2017 | RMD | M 10b5-1 | 22,660 | $33.70 | $763,642 | 120,247 Direct | +23.22% | Acquired | 549.5% (price as of 2026-10-02) |
| June 14, 2017 | PCRX | A | 2,714 | · | · | 2,714 Direct | · | Acquired | (price as of 2026-10-02) |
| June 14, 2017 | PCRX | A | 1,357 | · | · | 23,537 Direct | +6.12% | Acquired | (price as of 2026-10-02) |
| June 14, 2017 | RMD | M 10b5-1 | 1,730 | · | · | 22,660 Direct | -7.09% | Disposed | (price as of 2026-10-02) |
| June 14, 2017 | RMD | S 10b5-1 | 1,730 | $76.00 | $131,480 | 97,587 Direct | -1.74% | Disposed | 188.0% (price as of 2026-10-02) |
| June 14, 2017 | RMD | M 10b5-1 | 1,730 | $33.70 | $58,301 | 99,317 Direct | +1.77% | Acquired | 549.5% (price as of 2026-10-02) |
| Nov. 16, 2016 | RMD | A | 4,429 | · | · | 97,587 Direct | +4.75% | Acquired | (price as of 2026-10-02) |
| Aug. 19, 2016 | RMD | M | 36,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 19, 2016 | RMD | S | 36,000 | $69.93 | $2,517,480 | 93,158 Direct | -27.87% | Disposed | 213.0% (price as of 2026-10-02) |
| Aug. 19, 2016 | RMD | M | 36,000 | $25.54 | $919,440 | 129,158 Direct | +38.64% | Acquired | 757.0% (price as of 2026-10-02) |
| June 15, 2016 | PCRX | A | 1,488 | · | · | 22,180 Direct | +7.19% | Acquired | (price as of 2026-10-02) |
| June 15, 2016 | PCRX | A | 2,975 | · | · | 2,975 Direct | · | Acquired | (price as of 2026-10-02) |
| March 11, 2016 | RMD | M 10b5-1 | 36,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| March 11, 2016 | RMD | S 10b5-1 | 36,000 | $60.00 | $2,160,000 | 93,158 Direct | -27.87% | Disposed | 264.8% (price as of 2026-10-02) |
| March 11, 2016 | RMD | M 10b5-1 | 36,000 | $23.88 | $859,680 | 129,158 Direct | +38.64% | Acquired | 816.6% (price as of 2026-10-02) |
| Nov. 19, 2015 | RMD | A | 20,492 | · | · | 20,492 Direct | · | Acquired | (price as of 2026-10-02) |
| June 3, 2015 | PCRX | A | 4,000 | · | · | 4,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 3, 2015 | PCRX | A | 2,000 | · | · | 20,692 Direct | +10.70% | Acquired | (price as of 2026-10-02) |
| March 13, 2015 | PCRX | P | 1,000 | $93.83 | $93,830 | 18,692 Direct | +5.65% | Acquired | -73.1% (price as of 2026-10-02) |
| Jan. 26, 2015 | RMD | M | 48,000 | · | · | 0 Indirect | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 26, 2015 | RMD | S | 48,000 | $66.77 | $3,204,960 | 93,158 Indirect | -34.00% | Disposed | 227.8% (price as of 2026-10-02) |
| Jan. 26, 2015 | RMD | M | 48,000 | $16.50 | $792,000 | 141,158 Indirect | +51.53% | Acquired | 1226.6% (price as of 2026-10-02) |
| Nov. 19, 2014 | RMD | A | 4,885 | · | · | 4,885 Direct | · | Acquired | (price as of 2026-10-02) |
Showing latest 100 of 178 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 14, 2026 | CRDF | Common Stock Purchase Warrant | Common Stock | $1.33 | · | 687,285 | Acquired |
| June 11, 2026 | CRDF | Stock Options | Common Stock | $1.59 | June 11, 2036 | 40,565 | Acquired |
| June 26, 2025 | CRDF | Stock Options | Common Stock | $3.16 | June 26, 2035 | 40,565 | Acquired |
| June 27, 2024 | CRDF | Stock Options | Common Stock | $2.33 | June 27, 2034 | 29,700 | Acquired |
| June 15, 2023 | CRDF | Stock Options | Common Stock | $1.59 | June 15, 2033 | 27,700 | Acquired |
| June 14, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.74 | June 14, 2033 | 12,925 | Acquired |
| May 11, 2023 | PCRX | Stock Option (Right to Buy) | Common Stock | $29.90 | June 12, 2023 | 7,000 | Disposed |
| June 8, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $59.39 | June 8, 2032 | 8,225 | Acquired |
| March 9, 2022 | CRDF | Stock Options | Common Stock | $2.50 | March 9, 2032 | 26,800 | Acquired |
| March 3, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $10.81 | June 4, 2022 | 7,000 | Disposed |
| March 1, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $11.02 | April 2, 2022 | 1,166 | Disposed |
| March 1, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $11.02 | April 2, 2022 | 193 | Disposed |
| Feb. 28, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $11.02 | April 2, 2022 | 18,834 | Disposed |
| Feb. 28, 2022 | PCRX | Stock Option (Right to Buy) | Common Stock | $11.02 | April 2, 2022 | 9,807 | Disposed |
| June 10, 2021 | CRDF | Stock Options | Common Stock | $7.98 | June 10, 2031 | 22,000 | Acquired |
| June 9, 2021 | PCRX | Stock Option (Right to Buy) | Common Stock | $60.96 | June 9, 2031 | 7,626 | Acquired |
| Sept. 25, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $16.67 | Aug. 16, 2022 | 70,000 | Disposed |
| June 17, 2020 | CRDF | Stock Options | Common Stock | $2.60 | June 17, 2030 | 28,858 | Acquired |
| June 9, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $47.65 | June 9, 2030 | 8,027 | Acquired |
| April 16, 2020 | CRDF | Stock Options | Common Stock | $0.98 | April 16, 2030 | 11,916 | Acquired |
| March 12, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 4,649 | Disposed |
| March 12, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $13.98 | June 2, 2021 | 5,000 | Disposed |
| March 12, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 7,438 | Disposed |
| March 12, 2020 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 4,649 | Disposed |
| June 5, 2019 | PCRX | Stock Option (Right to Buy) | Common Stock | $43.54 | June 5, 2029 | 8,437 | Acquired |
| June 13, 2018 | PCRX | Stock Option (Right to Buy) | Common Stock | $38.35 | June 13, 2028 | 4,693 | Acquired |
| May 8, 2018 | RMD | ResMed Stock Options | ResMed Common Stock | $27.58 | Nov. 16, 2018 | 28,403 | Disposed |
| June 15, 2017 | RMD | ResMed Common Stock Options | ResMed Common Stock | $33.70 | Nov. 11, 2017 | 22,660 | Disposed |
| June 14, 2017 | PCRX | Stock Option (Right to Buy) | Common Stock | $44.20 | June 14, 2027 | 2,714 | Acquired |
| June 14, 2017 | RMD | ResMed Common Stock Options | ResMed Common Stock | $33.70 | Nov. 11, 2017 | 1,730 | Disposed |
| Aug. 19, 2016 | RMD | ResMed Common Stock Options | ResMed Commmon Stock | $25.54 | Dec. 17, 2016 | 36,000 | Disposed |
| June 15, 2016 | PCRX | Stock Option (Right to Buy) | Common Stock | $40.34 | June 15, 2026 | 2,975 | Acquired |
| March 11, 2016 | RMD | ResMed Common Stock Options | ResMed Commmon Stock | $23.88 | July 7, 2016 | 36,000 | Disposed |
| Nov. 19, 2015 | RMD | ResMed Common Stock Options | ResMed Commmon Stock | $58.24 | Nov. 19, 2022 | 20,492 | Acquired |
| June 3, 2015 | PCRX | Stock Option (Right to Buy) | Common Stock | $79.43 | June 3, 2025 | 4,000 | Acquired |
| Jan. 26, 2015 | RMD | ResMed Common Stock Options | ResMed Commmon Stock | $16.50 | July 1, 2015 | 48,000 | Disposed |
| Aug. 18, 2014 | RMD | ResMed Common Stock Options | ResMed Common Stock | $21.02 | Nov. 7, 2014 | 36,000 | Disposed |
| June 3, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $81.00 | June 3, 2024 | 8,000 | Acquired |
| Feb. 18, 2014 | RMD | ResMed Common Stock Options | ResMed Common Stock | $12.74 | July 2, 2014 | 48,000 | Disposed |
| Nov. 13, 2013 | RMD | ResMed Stock Options | ResMed Common Stock | $51.25 | Nov. 13, 2020 | 20,713 | Acquired |
| Sept. 9, 2013 | RMD | ResMed Stock Options | ResMed Common Stock | $23.10 | Nov. 10, 2013 | 12,000 | Disposed |
| June 12, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $29.20 | June 11, 2023 | 7,000 | Acquired |
| Nov. 15, 2012 | RMD | ResMed Stock Options | ResMed Common Stock | $38.98 | Nov. 15, 2019 | 25,934 | Acquired |
| Aug. 17, 2012 | PCRX | Stock Option (right to buy) | Common Stock | $16.67 | Aug. 16, 2022 | 70,000 | Acquired |
| Aug. 7, 2012 | RMD | ResMed Stock Options | ResMed Common Stock | $9.80 | July 7, 2013 | 48,000 | Disposed |
| June 5, 2012 | PCRX | Common Stock | Common Stock | $10.81 | June 4, 2022 | 7,000 | Acquired |
| April 3, 2012 | PCRX | Common Stock | Common Stock | $11.02 | April 2, 2022 | 20,000 | Acquired |
| April 3, 2012 | PCRX | Common Stock | Common Stock | $11.02 | April 2, 2022 | 10,000 | Acquired |
| Jan. 27, 2012 | RMD | ResMed Stock Options | ResMed Common Stock | $6.80 | July 5, 2012 | 48,000 | Acquired |
| Nov. 16, 2011 | RMD | ResMed Stock Options | ResMed Common Stock | $27.58 | Nov. 16, 2018 | 28,403 | Acquired |
| June 22, 2011 | RMD | ResMed Common Stock Options | ResMed Common Stock | $13.05 | July 6, 2011 | 64,000 | Disposed |
| June 22, 2011 | RMD | ResMed Common Stock Options | ResMed Common Stock | $13.05 | July 6, 2011 | 64,000 | Disposed |
| June 2, 2011 | PCRX | Stock option (right to buy) | Common Stock | $13.98 | June 2, 2021 | 5,000 | Acquired |
| Nov. 11, 2010 | RMD | ResMed Stock Options | ResMed Common Stock | $33.70 | Nov. 11, 2017 | 24,390 | Acquired |
| Feb. 19, 2010 | RMD | ResMed Common Stock | ResMed Common Stock | $13.28 | July 7, 2010 | 32,000 | Disposed |
| Feb. 19, 2010 | IMNN | Common Stock Option | Celsion Common Stock | $2.94 | Feb. 19, 2020 | 25,000 | Acquired |
| Dec. 17, 2009 | RMD | ResMed Stock Options | ResMed Common Stock | $51.08 | Dec. 17, 2016 | 18,000 | Acquired |
| May 11, 2009 | RMD | ResMed Stock Options | ResMed Common Stock | $8.50 | July 2, 2009 | 10,666 | Disposed |
| Jan. 19, 2009 | IMNN | Common Stock Options | Common Stock Options | $2.72 | Jan. 19, 2019 | 8,333 | Acquired |
| Jan. 19, 2009 | IMNN | Common Stock Options | Common Stock Options | $2.72 | Jan. 19, 2019 | 8,333 | Acquired |
| Jan. 19, 2009 | IMNN | Common Stock Options | Common Stock Options | $2.72 | Jan. 19, 2019 | 8,334 | Acquired |
| Nov. 20, 2008 | RMD | ResMed Common Stock | ResMed Common Stock | $31.04 | Nov. 20, 2015 | 18,000 | Acquired |
| March 15, 2008 | IMNN | Commmon Stock Options | Common Stock | $5.47 | March 15, 2008 | 8,334 | Acquired |
| March 15, 2008 | IMNN | Common Stock Options | Common Stock | $5.47 | March 15, 2018 | 8,333 | Acquired |
| March 15, 2008 | IMNN | Common Stock Options | Common Stock | $5.47 | March 15, 2018 | 8,333 | Acquired |
| Nov. 7, 2007 | RMD | ResMed Common Stock | ResMed Common Stock | $42.05 | Nov. 6, 2014 | 18,000 | Acquired |
| March 22, 2007 | IMNN | Stock Option | Common Stock | $4.16 | March 22, 2017 | 25,000 | Acquired |
| Nov. 10, 2006 | RMD | ResMed Common Stock | ResMed Common Stock | $46.19 | Nov. 9, 2013 | 6,000 | Acquired |
| Nov. 10, 2006 | RMD | ResMed Common Stock | ResMed Common Stock | $46.19 | Nov. 9, 2016 | 6,000 | Acquired |
| Nov. 10, 2006 | RMD | ResMed Common Stock | ResMed Common Stock | $46.19 | Nov. 9, 2016 | 6,000 | Acquired |
| July 7, 2006 | RMD | ResMed Stock Options | ResMed Common Stock | $47.75 | July 6, 2016 | 18,000 | Acquired |
| March 15, 2006 | IMNN | Stock Option | Common Stock | $4.08 | March 15, 2016 | 3,676 | Acquired |
| July 1, 2005 | RMD | ResMed Common Stock Options [F1] | ResMed Common Stock | $65.99 | July 2, 2014 | 12,000 | Acquired |
| Feb. 22, 2005 | IMNN | Stock Options | common stock | $0.57 | Feb. 22, 2015 | 55,000 | Acquired |
| July 2, 2004 | RMD | ResMed Options [F1] | ResMed Common Stock | $50.95 | July 2, 2014 | 12,000 | Acquired |
| July 7, 2003 | RMD | ResMed Options | ResMed Common Stock | $39.19 | July 6, 2013 | 4,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.